WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Fermer ce répertoireAntiseptic agents
Afficher le documentAluminium diacetate
Afficher le documentPotassium permanganate
Afficher le documentSilver nitrate
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Aluminium diacetate

Solution, 13% (for dilution)

General information

Aluminium diacetate solution is an astringent that is used as an antiseptic agent. It is poorly absorbed, even when applied to damaged skin.

Clinical information

Uses

An antiseptic agent used in wet dressings to assist healing of suppurating superficial wounds, tropical ulcers and lesions caused by pemphigus and impetigo.

Dosage and administration

All doses are suitable for adults and children.

Suppurating superficial wounds and tropical ulcers:

A 1:20 (0.65%) dilution of the stock solution is used in wet dressings. The dressings should be applied for 0.5-2.0 hours each day and changed every 5-15 minutes. For tropical ulcers, a 2- to 4-week course of treatment with procaine benzylpenicillin is also required (see Benzylpenicillins - Tropical Ulcers).

Pemphigus:

Compresses soaked in a 1:2.6 (5%) dilution of the stock solution are applied every 4 hours.

Impetigo:

Superficial crusts should be gently separated with a 1:20 (0.65%) dilution of the stock solution.

Precautions

Dressings should not be applied under plastic or rubber occlusion.

Adverse effects

No adverse effects have been reported.

Storage

Solutions should be stored in well-closed containers.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012